GLP-1 NAION Vision Loss Lawsuit

Medications used for diabetes and weight loss — including Ozempic, Wegovy, Mounjaro, and Zepbound — have been linked to a significantly increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a serious eye condition that can lead to permanent vision loss or blindness.

Recent medical studies suggest that manufacturers Novo Nordisk and Eli Lilly may have failed to adequately warn patients and doctors about these risks. Individuals who developed NAION or sudden vision loss after taking GLP-1 medications may be eligible for compensation.

Open and accepting new clients.

🔍 What's Being Investigated?

Lawsuits allege that GLP-1 receptor agonists prescribed for diabetes and weight loss increase the risk of NAION and other serious injuries. Claims focus on whether drugmakers failed to properly warn patients about vision loss risks.

⚠️ Reported Injuries

  • NAION (optic nerve damage)
  • Sudden vision loss in one or both eyes
  • Blurred, foggy, or shadowed vision
  • Permanent partial or total blindness
  • Severe gastrointestinal complications

📊 Scientific Evidence

  • JAMA Ophthalmology: Up to 7x higher NAION risk
  • Danish nationwide study: 2x increased risk
  • Multiple peer-reviewed studies (2024-2025)
  • Cases of rapid progression to blindness

👁️ What Is NAION?

NAION is caused by reduced blood flow to the optic nerve. There is currently no proven treatment to reverse the damage once it occurs, making the condition life-altering for many patients

👩‍⚖️ Who May Qualify?

  • Patients prescribed GLP-1 medications
  • Diagnosis of NAION or sudden vision loss
  • Use of Ozempic, Wegovy, Mounjaro, Zepbound, or similar drugs
  • Family members of affected individuals

⚖️ Current Legal Status

  • Federal MDL under consideration
  • Cases pending against Novo Nordisk & Eli Lilly
  • EMA investigation launched January 2025
  • Potential settlements and compensation
Click here to visit 4grewallaw.com
Program Image

All information is encrypted and confidential

Other reasons why you can trust in Grewal Law PLLC:

1

We have been helping clients across the United States for decades.

2

We are highly praised and recommended by past clients.

3

We have a long track record of winning settlements and verdicts.


STRICTEST CONFIDENCE


Because of the sensitivity of the case we will be addressing with you, all names and information will be kept in the strictest confidence at all times. If you or a loved one took GLP-1 Drug (Such as Ozempic, Mounjaro, or Wegovy) and later experienced serious side effects or health complications, you may be eligible for compensation.



Image


Dedicated to helping GLP-1 Drug (Ozempic, Mounjaro, or Wegovy) victims, our legal team brings over a decade of experience securing major settlements and verdicts for clients harmed by unsafe pharmaceuticals.

Image
Image
Image
Image



Not available in all states. The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. We are not affilaited with Facebook. This is an advertisement. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship.